Functional foods with dipeptidyl peptidase‐4 inhibitory potential and management of type 2 diabetes: A review
Abstract The global high prevalence of diabetes mellitus has resulted into the development of several oral hypoglycemic agents. However, these drugs have limited efficacy and harmful side effects, which call for the search for alternatives from natural sources. The inhibition of dipeptidyl peptidase...
Main Authors: | Mutiu Kazeem, Habeeb Bankole, Olabisi Ogunrinola, Adedoja Wusu, Abidemi Kappo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-06-01
|
Series: | Food Frontiers |
Subjects: | |
Online Access: | https://doi.org/10.1002/fft2.71 |
Similar Items
-
Incretins as a Potential Treatment Option for Gestational Diabetes Mellitus
by: Aleksandra Pilszyk, et al.
Published: (2022-09-01) -
Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes
by: Anand-Krishna Singh, et al.
Published: (2021-06-01) -
Acute pancreatitis with gliptins: Is it a clinical reality?
by: Muthukrishnan Jayaraman, et al.
Published: (2013-01-01) -
Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions
by: Awadhesh Kumar Singh
Published: (2014-01-01) -
Choosing a Gliptin
by: Vishal Gupta, et al.
Published: (2011-01-01)